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Abstract
Background: Migraine is a complex, chronic, painful, neurovascular disorder characterized by
episodic activation of the trigeminal system. Increased levels of calcitonin gene-related peptide
(CGRP) are found at different levels during migraine attacks. Interestingly, CGRP is also released
within the trigeminal ganglia suggesting possible local effects on satellite cells, a specialized type of
glia that ensheaths trigeminal neurons. CGRP was shown to enhance satellite-cell production of
interleukin 1β (IL-1β), while trigeminal neurons express an activity-dependent production of nitric
oxide (NO). Thus, in the present study we tested the hypothesis that IL-1β and NO induce
trigeminal satellite cell activation, and that once activated these cells can influence neuronal
responses.
Results: Primary cultures of rat trigeminal satellite cells isolated from neuronal cultures were
characterized in vitro. Cyclooxygenase (COX) expression and activity were taken as a marker of
glial pro-inflammatory activation. Most of the experiments were carried out to characterize
satellite cell responses to the two different pro-inflammatory stimuli. Subsequently, medium
harvested from activated satellite cells was used to test possible modulatory effects of glial factors
on trigeminal neuronal activity. IL-1β and the NO donor diethylenetriamine/nitric oxide (DETA/
NO) elevated PGE2 release by satellite cells. The stimulatory effect of IL-1β was mediated mainly
by upregulation of the inducible form of COX enzyme (COX2), while NO increased the
constitutive COX activity. Regardless of the activator used, it is relevant that short exposures of
trigeminal satellite cells to both activators induced modifications within the cells which led to
significant PGE2 production after removal of the pro-inflammatory stimuli. This effect allowed us
to harvest medium from activated satellite cells (so-called 'conditioned medium') that did not
contain any stimulus, and thus test the effects of glial factors on neuronal activation. Conditioned
medium from satellite cells activated by either IL-1β or NO augmented the evoked release of
CGRP by trigeminal neurons.
Conclusion: These findings indicate that satellite cells contribute to migraine-related
neurochemical events and are induced to do so by autocrine/paracrine stimuli (such as IL-1β and
NO). The responsiveness of IL-1β to CGRP creates the potential for a positive feedback loop and,
thus, a plurality of targets for therapeutic intervention in migraine.
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Migraine is a complex, chronic, painful, neurovascular
disorder characterized by episodic activation of the
trigeminal system; in particular, trigeminal ganglia play a
pivotal role in initiating and maintaining pain [1,2]. Cell
bodies of trigeminal neurons extend their axonal projec-
tions to the brainstem nuclei, which mediate the trans-
mission of nociceptive information to the higher brain
centers where pain is perceived. On the other side, periph-
eral nociceptive fibers arising from trigeminal neurons
innervate cerebral vessels as well as vessels within the dura
and pia mater, i.e. the cranial structures likely responsible
for pain in migraine [3]. Several neuropeptides have been
identified in the trigeminal ganglia, including substance
P, neurokinin A, and calcitonin gene-related peptide
(CGRP). The latter is thought to be the main neuromedi-
ator of trigeminal signaling, particularly in headache [4].
In fact, increased levels of CGRP are found in the jugular
vein during migraine attacks [5], and an increase in CGRP
release occurs during peripheral sensitization of menin-
geal nociceptors, which is responsible for hyperalgesia
and allodynia often associated with migraine [6].
CGRP is also released in a paracrine/autocrine manner
within the trigeminal ganglia [7,8], suggesting a role as a
local modulator. Moreover, sustained activation of sen-
sory neurons is associated with increased nitric oxide
(NO) production from neuronal NO synthase (nNOS) [9-
11]. Because of its physico-chemical properties, NO can
rapidly diffuse among the cells and modulate intracellular
functions, as well as extracellular events such as neuro-
transmitter receptor activation. Interestingly, trigeminal
neurons are surrounded by glial cells, referred to as satel-
lite cells; both cell types form functional units within the
tissue [12]. Satellite cells appear to respond to neuronal
activity with the secretion of factors that can modulate
such activity [13]. In particular, intraganglionic CGRP
induces satellite cells to produce cytokines [14], among
which IL-1β, along with other inflammatory mediators
such as NO [7]. At the present, the impact of these inflam-
matory mediators on glial functions is not fully clarified.
In this study, we tested the hypothesis that IL-1β and NO
can induce trigeminal satellite cell activation, and that
once activated these cells may influence neuronal
responses. Thus, we developed primary cultures of rat
trigeminal satellite cells and characterized their activation
in vitro. Subsequently, medium harvested from activated
satellite cells was used to test possible modulatory effects
of glial factors on trigeminal neuronal activity. This exper-
imental model allowed us to study components of a cycli-
cal satellite-neuron interaction, beginning at the point of
inflammatory stimuli. We found that both IL-1β and NO
stimulated an increased production of PGE2, although
the underlying activations of COX were mechanistically
distinct. Once such activation was characterized, we used
these satellite cells to generate conditioned media that
were tested on primary cultures of trigeminal neurons to
investigate the possible influence of glial factors on neu-
ronal CGRP release. Conditioned medium from activated
satellite cells augmented CGRP release evoked by a stand-
ard depolarizing agent. Our data clearly suggest that satel-
lite cells, besides providing a mechanical and metabolic
support to neurons, directly modulate their functions. A
patho-physiological feed-forward loop between satellite
cells and neurons may thus contribute to migraine. This
view provides the opportunity for multiple -and, perhaps,
combinatorial -therapeutic strategies because interrupting
either the glial or the neuronal end of this interaction
should break the cycle and effect attenuation of migraine
duration and/or intensity.
Results
Morphological and functional characterization of rat 
trigeminal satellite cells in vitro
Rat trigeminal satellite cells were isolated from dissociated
suspensions of trigeminal ganglia, exploiting their ten-
dency to firmly adhere to the bottom of uncoated culture
flasks [15]. Cells were subcultured twice and further
expanded in vitro, then used for functional experiments
once they reached almost complete confluence (Figure 1).
Two specific markers of glial cells, the glial fibrillary acidic
protein (GFAP) and the glutamine synthase (GS), were
expressed in trigeminal satellite cells. As shown in Figure
2, it is possible to distinguish two types of satellite glial
cells via morphological and immunological phenotypes.
Primary cultures of trigeminal satellite cellsFigure 1
Primary cultures of trigeminal satellite cells. Morphol-
ogy of a primary culture of rat satellite cells was observed 
under phase-contrast microscopy. The predominant pheno-
type consists of small and dark cells with an elongated shape. 
(10× – 50 μm scale bar)Page 2 of 13
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GFAP and GS and have a small cell body with an elon-
gated shape; roughly 35% of the total cells stained weakly
for the two glial markers and have an astrocyte-like mor-
phology. In preliminary experiments we studied the
effects of different proinflammatory stimuli on satellite
cell activation, taking the levels of PGE2 released in the
incubation media as a marker of cellular inflammatory
response. Under basal conditions primary cultures of
trigeminal satellite cells release sizable amounts of PGE2
in a time-dependent manner (Figure 3). IL-1β (10 ng/ml)
significantly increased PGE2 release from 8 h onward
(Figure 3A). Other proinflammatory cytokines, such as
IFNγ (10 UI/ml) and TNFα (10 ng/ml), produced no
effect on PGE2 after 24 h treatments (data not shown). In
preliminary experiments, we found that the NO donor
DETA/NO increased PGE2 release after 6 h, with a peak
response produced by 100 μM DETA/NO; therefore, this
concentration was used in all subsequent experiments.
DETA/NO significantly increased PGE2 release after 6 and
8 h, while a significant inhibitory effect was observed at
12 h of incubation (Fig. 3B). The levels of PGE2 measured
after 8 h of exposure to DETA/NO were lower than those
induced by an 8-h treatment with IL-1β, suggesting that
different molecular mechanisms are recruited by the two
stimuli.
Some effects of NO are mediated by the activation of the
soluble guanylyl cyclase (sGC) and the subsequent
increase in intracellular cGMP levels. In the range 1 nM-1
μM, the sGC inhibitor NS2028 significantly reduced the
stimulatory effect of DETA/NO (Fig. 4A). At higher con-
centrations, NS2028 even inhibited basal PGE2 release.
Consistent with these data, we found that the stable and
cell-permeable cGMP analog 8-Br-cGMP increased PGE2
release after 4-h and 8-h treatments, with significant
effects observed at 100 μM (Figure 4B). Taken together,
these results indicate that the stimulatory effects of DETA/
NO are mediated at least in part by increased levels of
cGMP.
Effects of pro-inflammatory stimuli on cyclooxygenase 
expression
Under resting conditions, cells of the immune-inflamma-
tory lineages mainly produce prostaglandins via the activ-
ity of the constitutive COX1, whereas inflammatory
situations evoke inductions of COX2. IL-1β significantly
increased expression of COX2 in trigeminal satellite cells
(Figure 5A). After a 4-h treatment, IL-1β evoked a 15-fold
increase in the levels of COX2 mRNA without influencing
COX1 mRNA levels (Figure 5B). DETA/NO appeared to
have a distinct mechanism of action; its stimulatory effect
Immunostaining of primary cultures of trigeminal satellite cellsFigure 2
Immunostaining of primary cultures of trigeminal 
satellite cells. Cells were stained with the nuclear dye 
DAPI (A). Immunocytofluorescence was performed with 
antibodies against the glial fibrillary acidic protein (GFAP) (B) 
and glutamine synthase (GS) (C). The same field is shown in 
all three panels, and a merged representation of the triple-
staining is presented in panel D. (40× – 50 μm scale bar)
Time-dependent increase of PGE2 release from rat trigemi-nal satellite c llsF gur  3
Time-dependent increase of PGE2 release from rat 
trigeminal satellite cells. Cells were incubated with or 
without tested stimuli 10 ng/ml IL-1β (A) or 100 μM DETA/
NO (B). PGE2 secretion was evaluated at different time 
points by RIA (up to 24 h for IL-1β). Data are expressed as 
pg/ml of PGE2, and are means ± SEM of n = 6 replicates for 
each experimental group. *** p < 0.001 vs. control (two-way 
ANOVA followed by Bonferroni's post-hoc test).
2h 4h 6h 8h 12h
0
100
200
300
400
500 Control
100 μM DETA/NO
P
G
E
2
, 
p
g
/m
l
B
***
***
***
A
2h 4h 8h 24h
0
500
1000
1500
Control
IL-1ȕ
***
***
P
G
E
2
, 
p
g
/m
lPage 3 of 13
(page number not for citation purposes)
Molecular Pain 2009, 5:43 http://www.molecularpain.com/content/5/1/43on PGE2 release was associated with only a modest
increase in COX1 mRNA levels observed after 6 h incuba-
tion (Figure 5D), while COX2 mRNA levels were reduced
(Figure 5C). Consistently, western blot analysis showed
increased amount of COX2 protein in the lysates of cells
treated with IL-1β for 4 h, while no effect was observed in
cells treated with DETA/NO (Figure 6A). In figure 6B a
densitometry analysis of the blot is reported; values for
COX2 protein levels are normalized by the density values
relative to the correspondent β-actin, as explained in
detail in the Methods. Furthermore, the stimulatory effect
of IL-1β on PGE2 release was completely antagonized by
the selective COX2 inhibitor NS398 given in the range of
3–30 μM. The inhibitory effect of NS398 was already max-
imal at 3 μM, a concentration equal to the IC50 calculated
for the purified enzyme (Figure 6C). In contrast, the selec-
tive COX1 inhibitor SC650, at 10 nM (~IC50), only par-
tially even though still significantly reduced PGE2
production increased by IL-1β (Figure 6D). Both 30 μM
NS398 and 100 nM SC560 significantly reduced basal
PGE2 release, thus suggesting that both isoforms contrib-
ute to prostaglandins production under basal condition.
However, data obtained using COX inhibitors in presence
of IL-1β support the notion that COX2 upregulation and
activity mainly mediates the stimulatory effects of IL-1β
on PGE2.
Effects of satellite cell conditioned media on neuronal 
activation
Satellite cells were incubated for different times with IL-1β
or DETA/NO to generate conditioned medium, subse-
quently used to test the effects of glial mediators on neu-
ronal CGRP release (see Methods). Similarly to the
experiments described in Figure 3, IL-1β increased PGE2
release in a time dependent manner and statistically sig-
nificance reached from 4 h onward (Figure 7A). The
effects of IL-1β were long-lasting, in fact pre-exposure of
trigeminal satellite cells to the cytokine elevated the levels
of PGE2 in the following 24 h incubation in plain
medium, regardless of the length of such preincubation
(Figure 7B). Trigeminal satellite cells were exposed to
DETA/NO for different times (2–8 h) and further incu-
bated in plain medium for 24 h after DETA/NO removal.
As shown in Figure 7C, significant increases in PGE2
release were observed after 6 and 8 h incubation, while an
even shorter pre-exposure to DETA/NO (4 h) increased
PGE2 release in the following 24 h incubation (Figure
7D). Higher levels of PGE2 were measured after 6 and 8 h
pre-incubation with DETA/NO (Figure 7D). Based upon
these results conditioned media from satellite cells acti-
vated for 4 h with IL-1β or 6 h with DETA/NO were used
on neuronal cultures.
Pre-exposure of trigeminal neurons for 30 min to IL-1β
conditioned medium (diluted to 50%) significantly
increased the release of neuronal CGRP evoked by 10 min
stimulation with 100 nM capsaicin (Figure 8A) [15]. In a
similar manner, conditioned media derived by satellite
cells activated with DETA/NO significantly enhance the
stimulatory effects of capsaicin (Figure 8B).
Discussion
In the present study we have characterized rat primary cul-
tures of trigeminal satellite cells, prepared after neuronal
removal, both under basal condition and after exposure to
different pro-inflammatory stimuli. Particularly, we
found that both the inflammatory cytokine IL-1β and the
gaseous mediator NO increase PGE2 production by
Involvement of cGMP signaling in the effects of DETA/NO on PGE2 rel aseFigur  4
Involvement of cGMP signaling in the effects of 
DETA/NO on PGE2 release. A: Cells were incubated for 
6 h with or without 100 μM DETA/NO. The guanylate 
cyclase inhibitor NS2028 was included as indicated. Data are 
expressed as pg/ml of PGE2 and are means ± SEM of n = 6 
for each experimental group. * p < 0.05, *** p < 0.001 vs con-
trol; °°° p < 0.001 vs DETA/NO alone. B: Cells were incu-
bated with the indicated concentrations of the stable and 
cell-permeable analog of cGMP, 8-Br-cGMP. Data are 
expressed as pg/ml of PGE2, as mean ± SEM of n = 6 repli-
cates for each experimental group. *** p < 0.001 vs. controls.
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mainly mediated by upregulation of the inducible form of
COX enzyme (COX2), NO seemed to act by increasing
COX activity without any relevant modification of the
expression of these enzymes. Regardless of the activator
used, it is relevant that short exposures of trigeminal satel-
lite cells to both activators induced modifications within
the cells which led to significant PGE2 production after
removal of the pro-inflammatory stimuli. This effect was
used to generate conditioned media from activated satel-
lite cells that did not contain any activators; such media
were used to test the effects of glial factors on neuronal
activation. In fact, within the sensory ganglia neurons are
unsheathed by several glial cells, forming morphological
and functional units [16], and neuronal-glial interactions
have been recently described in vivo, suggesting that satel-
lite cells can modulate neuronal activity in several man-
ners [17,18]. Satellite cells are thought to actively
participate to pain transmission [12] since they regulate
the local ganglion environment by removing the excess of
ions and neurotrasmitters [16]. Moreover, several recep-
tors, including those for IL1β, have been detected on the
surface of satellite cells under basal conditions [19], while
other receptors can be expressed during pathological proc-
esses among which those for inflammatory cytokines
[20]. Thus, it may be hypothesized that trigeminal satellite
cells are activated during neurogenic inflammation, and
promote and maintain activation of trigeminal neurons
by releasing pro-inflammatory mediators. One of the
most important pathways in the development of neuronal
sensitization is the activation of COX enzymes leading to
increased prostaglandin production. These mediators do
not interfere directly with neuronal neurotransmitter
release, such as CGRP release, but can reduce the firing
threshold of sensory neurons in response to other depo-
larizing agents [21,22]. In light of this evidence, we
IL-1β and DETA/NO differentially induce COX1 and COX2 expression in rat trigeminal satellite cellsFigure 5
IL-1β and DETA/NO differentially induce COX1 and COX2 expression in rat trigeminal satellite cells. Satellite 
cells were incubated with 10 ng/ml IL-1β (A and B) or 100 μM DETA/NO (C and D) for the indicated times, then total RNA 
was extracted. Expression of COX2 (A and C) or COX1 (B and D) was evaluated by real-time (Q) RT-PCR using the com-
parative quantitation analysis. Data are expressed as the signal of mRNA from treated cultures relative to that from untreated 
controls (± SEM; n = 3); data were compiled from two independent experiments. ** p < 0.01, *** p < 0.001 vs. controls.
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Molecular Pain 2009, 5:43 http://www.molecularpain.com/content/5/1/43focused our studies on COX expression and activity, par-
ticularly considering the important role of prostaglandins
in mediating neuronal sensitization [23]. Moreover, our
experimental model allowed us to study possible neuro-
nal-glial interactions in a controlled simplified paradigm.
IL-1β increased in a time dependent manner the release of
PGE2, which paralleled significant induction of COX2
mRNA expression and protein synthesis (Figures 5 and 6).
Data obtained with selective pharmacological inhibitors
of COX activity, showed the involvement of both enzyme
in mediating PGE2 release by satellite cells. However, in
response to IL-1β challenge COX2 activity appears to be
predominant. The signaling pathways underlying the
effects of IL-1β are well characterized, and include the acti-
vation of membrane bound IL-1 receptors that triggers a
complex cascade of phosphorylations leading to down-
stream activation of Inhibitor-kB kinase (IKK) and
mitogen activated protein kinases (MAPKs), as well as of
transcription factors such as NF-kB [24]. These kinases
and activated NFkB are known inducers of COX2 expres-
sion [25]. Even though we did not thoroughly explore the
molecular mechanisms underlying the stimulatory effects
of IL-1β, we may reasonably postulate the involvement of
such mechanisms, in the same manner as they occur in
several other cell types expressing IL-1β receptors. Particu-
larly, IL-1β-dependent COX2 induction and PGE2 pro-
duction have been described in glial cells in several
COX-2 protein expression induced by IL-1β in trigeminal satellite cellsFigure 6
COX-2 protein expression induced by IL-1β in trigeminal satellite cells. (A) Whole-cell lysates were prepared from 
control satellite cells or cell treated with either IL-1β or DETA/NO for 4 h (2 replicates per each treatment), and equal 
amounts of protein were analyzed by western blot analysis for COX-2. The same blots were subsequently probed for β-actin. 
(B) Quantitation of densitometry wherein COX-2 values are reflected relative to those for β-actin. Data are expressed as 
mean ± SEM of n = 2 replicates for each group, each assayed in triplicates. *** p < 0.001 vs. controls. Satellite cells were incu-
bated in presence of 10 ng/ml IL-1β together with the selective COX2 inhibitor, NS398 (C) or the selective COX1 inhibitor, 
SC560 (D) for 8 h. Data are expressed as pg/ml of PGE2, as mean ± SEM of n = 5 replicates for each experimental group. *** 
p < 0.001 vs. controls; °°° p < 0.001 vs IL-1β alone.Page 6 of 13
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Alzheimer's disease [26]. Reactive glial cells actively par-
ticipate in central sensitization during chronic pain, and
their activation mediates pain hypersensitivity [27,28].
The role of activated glial cells and their interactions with
neurons in the transmission of pain sensation has been
extensively studied in specific brain areas and in the spinal
cord during pain disorders [28,29]. Conversely, the rele-
vance of glial activation within the peripheral sensory
ganglia, and their contribution in mediating pain signal-
ing, are not yet fully clarified. Several experimental data
suggest that proinflammatory cytokines such as IL-1β are
released in peripheral sites of inflammation from
immune cells and may affect neuronal excitability in a
paracrine/endocrine manner [20,30-32]. Indeed, IL-1β is
able by itself to promote neuronal discharge; the cytokine
also sensitizes neurons to other stimuli lowering the neu-
ronal firing threshold, via the modulation of different ion
fluxes (e.g. Na+, and K+) [33-35]. On the other hand, IL-1β
contributes to the amplification of inflammatory proc-
esses promoting the production of secondary modulators
such as NO, bradykinin and prostaglandins, which can in
turn exert modulatory actions on neuronal activity [9,36].
Recently, it has been shown that CGRP is also released
within the trigeminal ganglia, possibly enhancing local
inflammation [7,8]. In fact, it has been demonstrated that
neuronal CGRP can increase the expression of several pro-
inflammatory genes among which IL-1β [7]. Thus, we
hypothesized that these pro-inflammatory mediators may
act locally to increase both glial and neuronal responses,
thereby sustaining the activation of the trigeminal system.
We have also shown that satellite glial cells can be acti-
vated in vitro by short term exposure to the NO donor,
DETA/NO. This drug slowly releases small amounts of
NO, with a half-life of 20 h, thus better mimicking the in
Persistent effects of pro-inflammatory stimuli on satellite cell activationFigure 7
Persistent effects of pro-inflammatory stimuli on satellite cell activation. Satellite cells were incubated for different 
times in presence of 10 ng/ml IL-1β (A) or 100 μM DETA/NO (C), and the levels of PGE2 in the medium were assayed by RIA. 
Then the cultures were washed and further incubated in fresh medium for an another 24 h (see Methods for details). PGE2 
that had accumulated during this 24 h incubation was assayed in the various treatment groups, i.e., different times of initial 
treatment in the presence of IL-1β (B) or DETA/NO (D). Data are expressed as pg/ml of PGE2, as mean ± SEM of n = 6 repli-
cates for each experimental group. **, p < 0.01; *** p < 0.001 vs. controls
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Molecular Pain 2009, 5:43 http://www.molecularpain.com/content/5/1/43vivo condition [37]. In fact, in dorsal root ganglia it has
been shown that depolarizing stimuli enhancing intracel-
lular Ca++ concentrations, such as capsaicin and bradyki-
nin, can increase NO production from clusters of nNOS
positive sensory neurons [10,11,38]. Interestingly, these
neurons were surrounded by cGMP positive satellite cells,
suggesting that NO may diffuse within the glia and acti-
vate sGC [39,40]. Apart from the fact that a pivotal role for
NO among all pain mediators has been clearly demon-
strated in migraine pathology [41-43], little is known
about its effects on trigeminal satellite cell functions. In
our model, DETA/NO induced a transient increase in
PGE2 production, an effect in part mediated by activation
of sGC. In fact, the sGC inhibitor NS2028 reduced the
stimulatory effects of DETA/NO, and the stable cGMP
analog, 8-bromo-cGMP, mimicked DETA/NO effects.
Moreover, NS2028 given alone reduced the basal release
of PGE2, indicating that cGMP contributes to the regula-
tion of COX activity. However, we cannot rule out other
possible mechanisms, such as the modulation of COX
activity via post-translational modifications of the
enzyme. These mechanisms have been described in sev-
eral cell cultures, but the NO-COX interaction has been
reported to produce different and even opposite effects
[44]. NO-dependent activation of COX can be related to
the antioxidant properties of NO, or it may be mediated
by the generation of superoxide or peroxynitrite radicals.
In this framework, it is important to consider the source
of NO release, whether constitutive or inducible NOS
activity, and thus the redox status of resting or inflamed
cells [44]. Nanomolar concentrations of NO in the sys-
tem, usually associated to nNOS activity, act as negative
modulator of NFkB, inducing down regulation of COX2
expression, whereas micromolar concentrations of NO
(via iNOS) upregulate COX2 [45]. In our model, we did
observe a reduction of COX2 mRNA levels after exposure
to DETA/NO, which produces a controlled release of low
amount of NO thus mimicking the production of
nanomolar concentrations of NO by nNOS activity [45].
However, the overall effect of NO on PGE2 production is
a stimulation lasting up to 8 h incubation time, which
suggests the involvement of alternative mechanisms for
NO, as for example a direct stimulatory effects on COX
activity or the induction of COX1.
These results support the hypothesis that glial cells can be
activated by changes in neuronal activity, and further
release glial factors that modulate neuronal responses.
Thus, to test this hypothesis we studied the effects of IL1β-
or NO- conditioned media on CGRP release from primary
cultures of trigeminal neurons. We have previously shown
that the depolarizing agent capsaicin increases CGRP
release from trigeminal neurons; this paradigm can be
used as a marker of neuronal activity [15]. Conditioned
media did not influence basal CGRP release, but were able
to significantly increase the stimulatory effects of capsai-
cin. Trigeminal neurons were pre-exposed to conditioned
media derived from both IL-1β and NO activated satellite
cells for 30 min, and then stimulated with 100 nM capsa-
icin for 10 min. Since both stimuli were no longer con-
tained in the conditioned media, the potentiating action
Conditioned media from activated satellite cells enhances GRP release from trigeminal n uronsFigure 8
Conditioned media from activated satellite cells 
enhances CGRP release from trigeminal neurons. Sat-
ellite cells were exposed to IL-1β for 4 h (A) or DETA/NO 
for 6 h (B), then washed and incubated in fresh medium for 
another 24 h, as described in Fig. 7. Aliquots of this second 
cycle of conditioned medium (lacking the initial activating 
stimuli) were applied to trigeminal neurons at a 1:1 dilution, 
and CGRP was measured. After 30 min, capsaicin (100 nM) 
was applied to evoke secretion of CGRP in trigeminal neu-
rons that had been pre-exposed to conditioned medium or 
not. Data are expressed as pg/well/10 min of CGRP, as mean 
± SEM of n = 6 replicates for each experimental group. ***, p 
< 0.001 vs. controls; °°° p < 0.001 vs. capsaicin alone.
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Molecular Pain 2009, 5:43 http://www.molecularpain.com/content/5/1/43observed on neurons is due to factors released by satellite
cells under IL-1 β or NO challenge.
Conclusion
In the present paper, we have characterized primary cul-
tures of rat trigeminal satellite cells and their activation in
vitro by two different proinflammatory stimuli relevant to
migraine pathology. As shown in the schematic (Figure
9), both stimuli increase COX activity in satellite cells
although with different molecular mechanisms. Moreo-
ver, conditioned media from activated glial cells induce
neuronal sensitization to depolarization. One possible
mediator of neuronal sensitization is PGE2, but other fac-
tors can contribute to such neuronal response. Interest-
ingly, modifications of neuronal responses occurred after
short-term exposure to glial-derived factors, which
strongly underlies the importance of glial-neuronal inter-
actions during trigeminal activation. In conclusion, satel-
lite cells are actively involved in the modulation of
trigeminal neuronal activity, can amplify and sustain
inflammatory processes within the ganglia. These glial
effects may be important in the pathophysiology of
migraine, and thus satellite cells can be envisioned a new
target in pain treatment.
Methods
Drugs
Diethylenetriamine/nitric oxide (DETA/NO) was pur-
chased by Sigma-Aldrich (St. Louis. MO), dissolved in dis-
tilled water and 10 mM aliquots were made. The selective
inhibitor of nitric oxide (NO)-sensitive soluble guanylyl
cyclase, NS 2028, was purchased by Alexis Biochemicals
(Lausen, Switzerland), dissolved in DMSO at 1 mM. 8-
Bromo-cGMP was purchased from Tocris Bioscience (Bris-
tol, UK) as sodium salt, dissolved in distilled water and 10
mM aliquots were made. All drug aliquots were stored at
-35°C. Human recombinant IL-1β (Endogen, Pierce Bio-
technology, Rockford, IL) was dissolved in distilled water
at the concentration of 40 μg/ml and stored in aliquots at
-80°C. All working dilutions were made using cell culture
medium. None of the tested compounds interfered with
radioimmunoassays.
Cell Cultures
Neuronal and satellite cell cultures from trigeminal gan-
glia were prepared from 6- to 7-day-old Wistar rats. The
use of animals for this experimental work was previously
approved by the Italian Ministry of Health (licensed
authorization to P. Navarra). Briefly, both trigeminal gan-
glia were aseptically removed. Tissues were collected in a
Petri dish containing 3–5 ml of ice-cold phosphate buffer
saline without Ca2+ and Mg2+ (PBS w/o; Sigma), supple-
mented with antibiotics (100 IU/ml penicillin and 100
μg/ml streptomycin; Sigma) and D-glucose (6 g/l). Tissues
were then digested in 5 mg/ml collagenase (Biochrom AG,
Berlin, Germany) for 20 min at 37°C, followed by 10 min
incubation with 0.125% trypsin (Biochrom) including
DNAse I (Sigma) treatment in the last 5 min of incuba-
tion. At the end of the incubation time, the enzyme solu-
tion was replaced with 5 ml Ham's F12 medium
(Biochrom), containing 10% heat-inactivated endotoxin-
free foetal calf serum (FCS; GIBCO, Invitrogen Corpora-
tion, Paisley, Scotland) and antibiotics (complete culture
medium). Cells were mechanically dissociated using a
Pasteur pipette, plated on a 25 cm2 flask, and incubated at
37°C in a humidified atmosphere containing 5% CO2 for
2–3 h (pre-plating). This step allowed us to separate satel-
lite cells from neurons using their differential adhesion
properties. Satellite cells retain several characteristics of
glial cells, such as the ability to firmly adhere to the bot-
tom of uncoated culture flasks [15]. At the end of the pre-
plating time, neurons were floating in the incubation
media and could be harvested by collecting the media.
Satellite cells remained attached to the flask, in which 5
ml of fresh complete culture medium were added. Satel-
lite cells were then incubated for a week, during which the
medium was replaced twice, until reaching almost com-
plete confluence. At this time, cells were detached from
the flask by a 5-min 0.05% trypsin-EDTA (Biochrom)
treatment at 37°C, resuspended in fresh complete culture
Mechanisms underlying neuron-glia interaction in trigeminal gangliFigure 9
Mechanisms underlying neuron-glia interaction in 
trigeminal ganglia. Satellite glial cells ensheath trigeminal 
neurons constituting a functional unit into the trigeminal gan-
glion, as represented in the schematic. It has been demon-
strated (dashed arrows) that trigeminal neurons release 
CGRP and NO within the ganglia during activation. CGRP 
was shown to increase IL1β secretion by trigeminal satellite 
cells (dashed arrows). Thus, IL-1β and the NO donor DETA/
NO (red) were tested on satellite cells. DETA/NO better 
mimics neuronal NO release generated by nNOS. Both stim-
uli increase glial COX activity, even though via different 
molecular mechanisms (arrows). Conditioned media har-
vested from glial cells challenged with both stimuli promote 
neuronal sensitization. Compounds exogenously added to 
trigeminal satellite cells in different experimental paradigms 
are indicated in red.
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96 well plates (100 μl/well) for functional experiments,
24 well plates (500 μl/well) for the preparation of condi-
tioned media and 6 well plates (2 ml/well) for COX
mRNA and protein analysis, respectively. Finally, for
immunocytochemistry studies, cells were seeded on glass
coverslips.
Neurons collected from the flask were plated at a density
of 100,000 cells/well in 24-well tissue culture plates, pre-
viously coated with poli-D-lysine (40 μg/ml; MW 70,000–
130,000, Sigma). The incubation volume was 1 ml/well of
complete culture medium (see above), enriched with 50
ng/ml of 2.5 S murine nerve growth factor (Alexis Bio-
chemicals). The culture medium was changed within 24 h
from seeding, and 20 μM cytosine arabinoside was added
to further reduce non-neuronal cell growth [15]. All exper-
iments were carried out 6–7 days after dissection, when
cells reached complete maturation [15].
Experimental procedures
In preliminary experiments we characterized the activa-
tion of satellite cells under different pro-inflammatory
stimuli. Cells were incubated for various times in com-
plete culture medium with or without the addition of 10
ng/ml IL-1β or 100 μM DETA/NO. At the end of the exper-
iments, media were collected and stored at -35°C until the
day of the radioimmunological assessment of PGE2 con-
tent. For the analysis of COX expression, cells were either
lysed in TRIZOL for mRNA analysis or in RIPA buffer
(composition below) for protein analysis. Lysates were
stored at -80°C until further processed.
To explore the molecular mechanisms underlying NO
effects, cells were activated for 6 h with 100 μM DETA/NO
alone or in presence of the soluble guanilyl cyclase inhib-
itor, NS2028 (1–1000 nM), or they were treated with 8-
Br-cGMP (1–100 μM).
Conditioned media from activated satellite cells was gen-
erated following a more complex protocol intended to
remove from the media the proinflammatory stimuli (IL-
1β or DETA/NO) to avoid direct effect of these agents on
neurons. Briefly, satellite cells were incubated in presence
of 10 ng/ml IL-1β or 100 μM DETA/NO for various times,
then this medium was removed and replaced with com-
plete culture medium. After a 24-h conditioning period,
this medium was collected and used in part to assess PGE2
release (results are shown in Figure 7), and in part was
stored at -80°C until the experiments on neurons were
performed. In the latter paradigm, conditioned media
from satellite cells activated for 4 h with IL-1β or 6 h with
DETA/NO were used. In preliminary experiments we
tested the effects of conditioned media generated from
resting satellite cells (100%) or satellite cell activated with
IL-1β (dilutions ranging between 12.5% and 100%) on
basal CGRP release from trigeminal neurons (30 min
incubation), and we did not observe any significant effect.
Therefore, neuronal cultures were pre-exposed to 50%
conditioned media generated by activated satellite cells
for 30 min and then further stimulated by 10 min incuba-
tion with a well characterized depolarizing stimulus, 100
nM capsaicin [15], in order to study the possible effects of
glial factors on neuronal activation. At the end of these
experiments, the medium was collected and stored at -
35°C until the assessment of CGRP by a specific radioim-
munoassay (RIA).
PGE2 and CGRP radioimmunoassays
PGE2 was measured by RIA as previously described in
detail [46]. Incubation mixtures of 1.5 ml were prepared
in disposable plastic tubes. Culture derived media sam-
ples (100 μl) were diluted to 250 μl with 0.025 M phos-
phate buffer (pH 7.5) and mixed with [3H]PGE2 (2,500–
3,000 cpm). Antiserum reactive against PGE2 (kindly pro-
vided by Prof. G. Ciabattoni) was added with sufficient
phosphate buffer to achieve a final dilution of 1:120.000
in a total incubation volume of 1.5 ml. A standard curve
was generated with duplicate aliquots of PGE2 at 2–400
pg/tube. After 24 h, free PGE2 was removed with activated
charcoal (Sigma). Supernatants (containing antibody-
bound PGE2) were combined with 10 ml liquid scintilla-
tion fluid, and radioactivity was measured by liquid scin-
tillation counting. The detection limit of the assay was 2
pg/tube and the EC50 40 pg/tube. The intra- and inter-
assay variability was 5 and 10% respectively.
CGRP release was measured by a specific RIA technique
validated in our laboratory and previously described in
detail [15]. Briefly, a buffer containing 10 mM sodium
phosphate, 154 mM NaCl, 25 mM ethylene diamine
tetraacetic acid (EDTA), 0.01% thimerosal, 0.5% BSA and
0.03% Tween 20, pH 7.2 was used. The RIA was per-
formed as follows: 100 μl of sample or standard solution
was diluted 3-fold into RIA buffer containing anti-hα-
CGRP (kindly provided by Prof. D. Currò) at a final dilu-
tion of 1:120,000. After 24 h at 4°C, 100 μl of [125I]-hα-
CGRP (6000 cpm/tube) was added and the incubation
continued at 4°C for 48 h. Separation of free from bound
α-CGRP was achieved by adding anti-rabbit goat serum
(at final dilution 1:200) and 500 μl of 6.6% polyethylene
glycol solution in 5 mM phosphate buffer, pH 7.4. After 2
h at 4°C, the tubes were centrifuged at 3000 × g for 30 min
at 4°C, and the pellet counted in a γ-counter. The standard
curve ranged from 1.95 to 1000 pg/tube of rα-CGRP. Each
sample and standard was assayed in duplicate. The mean
IC50 of the standard curve was 50.8 ± 2.0 pg/tube (n = 10)
and non-specific binding of the labeled ligand was not
different from the background of the γ-counter. The intra-
assay (n = 6) and inter-assay (n = 10) coefficients of varia-Page 10 of 13
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(1.95 pg/tube) and 13.7% and ± 12.6% at the highest
(1000 pg/tube) levels of standard. The detection limit was
19.5 pg/ml.
mRNA analysis
Total cytoplasmic RNA was extracted from satellite cells
using TRIZOL (Invitrogen). RNA concentration was meas-
ured using the Quant-iT™ RiboGreen® RNA Assay Kit (Inv-
itrogen). In each assay, a standard curve in the range of 0–
100 ng RNA was run using 16S and 23S ribosomal RNA
(rRNA) from E. coli as standard. Aliquots (1 μg) of RNA
were converted to cDNA using random hexamer primers.
Quantitative changes in mRNA levels were estimated by
real time PCR (Q-PCR) using the following cycling condi-
tions: 35 cycles of denaturation at 95°C for 30 sec; anneal-
ing at 59°C for 60 sec; and extension at 72°C for 60 sec;
using the Brilliant SYBR Green QPCR Master Mix 2×
(Stratagene, La Jolla, CA). PCR reactions were carried out
in a 20 μL reaction volume in a MX3000P real time PCR
machine (Stratagene). The primers used for COX2 were:
677F (5'-GCA TTC TTT GCC CAG CAC TTC ACT-3'), and
774R (5'-TTT AAG TCC ACT CCA TGG CCC AGT-3'),
which yield a 98 bp product. The primers used for COX1
detection were: 154F (5'-CCT CAC CAG TCA ATC CCT
GT-3'), and 384R (5'-AGG TGG CAT TCA CAA ACT CC-
3'), which yield a 231 base pair (bp) product. The primers
used for GAPDH were: 1505F (5'-TCC CAG AGC TGA
ACG GGA AGC TCA GTG-3'), e 1818R (5'-TGG AGG CCA
TGT AGG CCA TGA GGT CCA-3'), which yield a 314 bp
product. Relative mRNA concentrations were calculated
from the take-off point of reactions (threshold cycle, Ct)
using the comparative quantitation method performed by
Stratagene software and based upon the -ΔΔCt method
[47]. This analysis approximates a given sample's target
mRNA (e.g., COX2) level relative to the mean of the target
mRNA levels in untreated controls ("calibrator" value),
thus permitting statistical analysis of deviation from the
mean even among the controls. Ct values for GAPDH
expression served as a normalizing signal. In each assay,
the PCR efficiency was also calculated using serial dilution
of one experimental sample; efficiency values between
94–98% were found for each primer set and taken into
account for the comparative quantitation analysis. At the
end of Q-PCR, the products were separated by electro-
phoresis through 2% agarose gels containing 0.1 μg/ml
ethidium bromide to ensure the product was the correct
size.
Western immunoblot
Cultures were washed twice in ice-cold PBS and lysed in
RIPA buffer (1 mM EDTA, 150 mM NaCl, 1% igepal, 0.1%
SDS, 0.5% sodium deoxycholate, 50 mM Tris-HCl, pH
8.0) containing protease inhibitor cocktail diluted 1:250
(Sigma). The protein content in each sample was deter-
mined by Bradford's method using bovine serum albumin
as standard. A 10-μg aliquot of protein was mixed 1:3 with
3× gel sample buffer (150 mM Tris-HCl pH 6.8, 7.5%
SDS, 45% glycerol, 7.5% of bromophenol blue, 15% β-
mercaptoethanol), boiled for 5 min, and separated
through 10% polyacrylamide SDS gels. Apparent molecu-
lar weights were estimated by comparison to colored
molecular weight markers (Biorad; Hercules, CA). After
electrophoresis, proteins were transferred to polyvinyli-
dene difluoride membranes by semi-dry electrophoretic
transfer. The membranes were blocked with 10% (w/v)
low-fat milk in TBST (10 mM Tris, 150 mM NaCl, 0.1%
Tween-20, pH 7.6) for 1 h at room temperature, and incu-
bated in the presence of anti-COX2 antibody (at 1:1,000
dilution) overnight with gentle shaking at 4°C. The pri-
mary antibody was removed, membranes washed three
times in TBST, and further incubated for 1 h at room tem-
perature in the presence of anti-rabbit IgG-HRP secondary
antibody, diluted 1:15,000. Following three washes in
TBST, bands were visualized by incubation in ECL rea-
gents for 5 min and exposure to X-ray film for 1 min. The
same membranes were washed 3 times in TBST, blocked
with 10% (w/v) low-fat milk in TBST for 1 h at room tem-
perature and used for β-actin immunoblot (incubating
with anti-β-actin antibody at 1:1000 dilution, overnight
with gentle shaking at 4°C and anti-mouse IgG-HRP sec-
ondary antibody, diluted 1:8000). Band intensities were
determined using ImageJ software (National Institutes of
Heatlh) from autoradiographs obtained from the mini-
mum exposure time that allow band detection, and back-
ground intensities (determined from an equal-sized area
of the film immediately above the band of interest) were
subtracted [48].
Immunocytofluorescence
For immunocytofluorescent characterization of rat
trigeminal satellite cell cultures, cells were plated at a den-
sity of 5000 cells/well on coated glass coverslips and kept
in culture for 3–4 days. At this time, cultures were washed
three times with PBS containing Ca2+ and Mg2+ (PBS-w)
and fixed in 4% paraformaldehyde for 20 min. After fixa-
tion, cultures were washed twice with PBS-w and blocked
with 0.5% BSA in PBS-w for 30 min. Primary antibodies
were diluted (1:1000 for mouse monoclonal anti-glial
fibrillary acidic protein, GFAP, Chemicon – Millipore
Corporation, Temecula, US; 1:500 for rabbit polyclonal
anti-glutamine synthase, GS, Sigma) in PBS-w containing
0.1% BSA and 0.2% Triton X100 and applied to cultures
overnight at 4°C. Secondary antibodies were horse anti-
mouse IgG conjugated to fluorescein and goat anti-rabbit
IgG conjugated to Texas Red (Vector Laboratories, Burlin-
game CA). Secondary antibodies were incubated for 1 h at
37°C and diluted 1:200 in PBS-w in 0.1% BSA. Coverslips
were mounted using Vectashield mounting media. Images
were obtained on a Nikon Eclipse TE300 inverted fluores-Page 11 of 13
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sional digital camera and LUCIA-G/F imaging software.
Statistical analysis
All data are presented as mean ± SEM, unless otherwise
stated. Significant differences between groups were
assessed by one-way or two-way analysis of variance
(ANOVA) followed by Bonferroni's post-hoc test. All data
were analysed using a PrismTM computer program
(GraphPad, San Diego CA, USA).
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